Post-earnings recap
Reported
Tue, Jul 21, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Illumina's strong EPS performance, exceeding expectations by over 68%, contributed to a positive stock reaction, with shares rising by 2.81%. The company did not provide revenue figures or future guidance, leaving some uncertainty for investors. However, management's focus on innovation suggests a commitment to growth in the competitive genomics market.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.30 | N/A | +68.54% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized the importance of maintaining market leadership.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and expanding our market presence.